Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirza, A.
Right arrow Articles by Axelrad, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirza, A.
Right arrow Articles by Axelrad, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Increased basal and induced tyrosine phosphorylation of the insulin- like growth factor I receptor beta subunit in circulating mononuclear cells of patients with polycythemia vera

AM Mirza, PN Correa and AA Axelrad

Department of Anatomy and Cell Biology, University of Toronto, Ontario, Canada.

We have previously shown that circulating progenitor cells in patients with polycythemia vera (PV) are hypersensitive to insulin-like growth factor I (IGF-I) with respect to erythroid burst formation in serum- free medium, and that this effect occurs through the IGF-I receptor. To investigate the molecular basis of this IGF-I hypersensitivity phenomenon, we examined tyrosine phosphorylation of the IGF-I receptor beta subunit in peripheral blood mononuclear cells (PBMNC) from eight PV patients and six normals. Cells were exposed to IGF-I at concentrations of 10(-8) and 10(-10) mol/L for 0, 1, 3, and 10 minutes, and then lysed. The IGF-I receptor beta subunit was immunoprecipitated, and the protein was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotted with antiphosphotyrosine antibody (4G10). We found that, in the absence of exogenous IGF-I, there was a basal level of tyrosine phosphorylation of the IGF-I receptor beta subunit, and it was substantially greater in PV than in normal. At 10(-10) mol/L IGF-I in normals, no evidence of increased tyrosine phosphorylation was detected; however in PV, a pronounced increase in tyrosine phosphorylation was observed at both 10(-10) and 10(-8) mol/L IGF-I, and it occurred earlier and attained a higher level than in normal. In contrast, in PBMNC from three patients with erythrocytosis, no significant increase above normal was seen in either basal or induced tyrosine phosphorylation of the IGF-I receptor beta subunit. Thus, our findings show two distinctive features of the PV phenotype in PBMNC: (1) an increased basal tyrosine phosphorylation of the IGF-I receptor beta subunit, and (2) a hypersensitive and hyperresponsive receptor with respect to tyrosine phosphorylation. These features may influence the ability of the receptor to transmit a proliferative signal; thus, they may play a role in the pathogenesis of PV.

Volume 86, Issue 3, pp. 877-882, 08/01/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Staerk, A. Kallin, J.-B. Demoulin, W. Vainchenker, and S. N. Constantinescu
JAK1 and Tyk2 Activation by the Homologous Polycythemia Vera JAK2 V617F Mutation: CROSS-TALK WITH IGF1 RECEPTOR
J. Biol. Chem., December 23, 2005; 280(51): 41893 - 41899.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-j. Xu, X. Sui, R. Zhao, C. Dai, S. B. Krantz, and Z. J. Zhao
PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells
Blood, December 15, 2003; 102(13): 4354 - 4360.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
A. Tefferi
Polycythemia Vera: A Comprehensive Review and Clinical Recommendations
Mayo Clin. Proc., February 1, 2003; 78(2): 174 - 194.
[Abstract] [PDF]


Home page
BloodHome page
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood, December 15, 2002; 100(13): 4272 - 4290.
[Full Text] [PDF]


Home page
BloodHome page
C. Dai and S. B. Krantz
Increased expression of the INK4a/ARF locus in polycythemia vera
Blood, June 1, 2001; 97(11): 3424 - 3432.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. A. Axelrad, D. Eskinazi, P. N. Correa, and D. Amato
Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia
Blood, November 15, 2000; 96(10): 3310 - 3321.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
T. C. Pearson, M. Messinezy, N. Westwood, A. R. Green, A. J. Bench, A. R. Green, B. J.P. Huntly, E. P. Nacheva, T. Barbui, and G. Finazzi
A Polycythemia Vera Update: Diagnosis, Pathobiology, and Treatment
Hematology, January 1, 2000; 2000(1): 51 - 68.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Zumkeller and S. Burdach
The Insulin-Like Growth Factor System in Normal and Malignant Hematopoietic Cells
Blood, December 1, 1999; 94(11): 3653 - 3657.
[Full Text] [PDF]


Home page
BloodHome page
A. R. Moliterno and J. L. Spivak
Posttranslational Processing of the Thrombopoietin Receptor Is Impaired in Polycythemia Vera
Blood, October 15, 1999; 94(8): 2555 - 2561.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Geissler, L. Ohler, M. Fodinger, E. Kabrna, M. Kollars, S. Skoupy, and K. Lechner
Interleukin-10 Inhibits Erythropoietin-Independent Growth of Erythroid Bursts in Patients With Polycythemia Vera
Blood, September 15, 1998; 92(6): 1967 - 1972.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. E. Damen, J. Krosl, D. Morrison, S. Pelech, and G. Krystal
The Hyperresponsiveness of Cells Expressing Truncated Erythropoietin Receptors Is Contingent on Insulin-Like Growth Factor-1 in Fetal Calf Serum
Blood, July 15, 1998; 92(2): 425 - 433.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Sui, S. B. Krantz, and Z. Zhao
Identification of Increased Protein Tyrosine Phosphatase Activity in Polycythemia Vera Erythroid Progenitor Cells
Blood, July 15, 1997; 90(2): 651 - 657.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-H. Dai, S. B. Krantz, and S. T. Sawyer
Polycythemia Vera V. Enhanced Proliferation and Phosphorylation Due to Vanadate Are Diminished in Polycythemia Vera Erythroid Progenitor Cells: A Possible Defect of Phosphatase Activity in Polycythemia Vera
Blood, May 15, 1997; 89(10): 3574 - 3581.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Clark
The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function
Endocr. Rev., April 1, 1997; 18(2): 157 - 179.
[Abstract] [Full Text]


Home page
BloodHome page
A. M. Mirza, S. Ezzat, and A. A. Axelrad
Insulin-Like Growth Factor Binding Protein-1 Is Elevated in Patients With Polycythemia Vera and Stimulates Erythroid Burst Formation In Vitro
Blood, March 15, 1997; 89(6): 1862 - 1869.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020